Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Satake Multimix Corporation maintains a presence in the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action currently under consideration. This action is being reviewed by 1 distinct examiner in 1 distinct art unit, which represents a consolidated approach to its current patent filings. This concentration indicates that the company's current intellectual property focus is likely on a specific chemical or biological mixing process that falls within a single technical domain.
STAVROU, CONSTANTINA E is the busiest examiner for this portfolio, managing 1 busiest_examiner_pending action. Since there is only 1 pending office action, the company's immediate prosecution outcomes are entirely dependent on the decisions made by this specific examiner within the biotechnology sector. Practitioners should carefully analyze the examiner's previous actions, as this single examiner controls the entirety of the company's current pending workload. The involvement of only 1 distinct art unit further emphasizes the specialized nature of the examination process for this portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STAVROU, CONSTANTINA E | 1 | 43.7% | +36.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258707 | CULTURED SPHERICAL BODY AND MANUFACTURING METHOD THEREFOR | STAVROU, CONSTANTINA E | 27d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258707 | CULTURED SPHERICAL BODY AND MANUFACTURING METHOD THEREFOR | STAVROU, CONSTANTINA E | 27d |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18258707 | CULTURED SPHERICAL BODY AND MANUFACTURING METHOD THEREFOR | STAVROU, CONSTANTINA E | 1632 | §103§112 | Final Rejection | 27d | Pending | Jun 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial